Search Ontology:
ChEBI
2-O-acetyl-1-O-octadecyl-sn-glycero-3-phosphocholine
- Term ID
- CHEBI:52450
- Synonyms
-
- (-)-1-O-octadeyl-2-O-acetyl-sn-glycerylphosphocholine
- (2R)-2-acetoxy-3-(octadecyloxy)propyl 2-(trimethylammonio)ethyl phosphate
- (2RR)-2-acetoxy-3-(octadecyloxy)propyl 2-(trimethylazaniumyl)ethyl phosphate
- (R)-7-(acetyloxy)-4-hydroxy-N,N,N-trimethyl-3,5,9-trioxa-4-phosphaheptaconasan-1-aminium hydroxide inner salt 4-oxide
- 1-0-octadecyl 2-0-acetyl sn-glycero-3-phosphorylcholine
- 1-O-octadecyl 2-O-acetyl sn-glycero-3-phosphorylcholine
- 1-O-octadecyl-2-acetyl-sn-glycero-3-phosphocholine
- 1-O-octadecyl-2-acetyl-sn-glyceryl-3-phosphorylcholine
- 1-O-octadecyl-2-O-acetyl-sn-glycero-3-phosphocholine
- 1-O-octadecyl-2-O-acetyl-sn-glyceryl-3-phosphorylcholine
- 1-O-octadecyl-PAF
- 1-O-octadecyl-platelet-activating factor
- 1-O-Stearoyl-2-acetyl-sn-glyceryl-3-phosphorylcholine
- 1-O-Stearyl-2-acetyl-sn-glyceryl-3-phosphorylcholine
- 1-octadecyl-2-acetyl-sn-glycero-3-phosphocholine
- acetyl-glyceryl-ether-phosphorylcholine
- AGEPC
- blood platelet activating factor-acether
- Blood platelet activating factor-aether
- Blood platelet-activating factor
- C18-Paf
- C18-PAF-acether
- C18:0 PAF
- PAF
- PAF acether
- PAF-acether
- PC(O-18:0/2:0)
- phosphatidylcholine (O-18:0/2:0)
- platelet activating factor
- platelet activating factor-acether
- platelet-activating factor
- Ro 14-8161
- Definition
- A 2-acetyl-1-alkyl-sn-glycero-3-phosphocholine betaine which has octadecyl as the alkyl group. PAF is a potent phospholipid activator and mediator of many leukocyte functions, including platelet aggregation, inflammation, and anaphylaxis.
- References
-
- Beilstein:5364572
- CAS:74389-69-8
- DrugBank:DB02261
- LIPID_MAPS_instance:LMGP01020094
- Reaxys:5364572
- Wikipedia:Platelet-activating_factor
- Ontology
- ChEBI ( EBI )
- is a type of
-
- has_role
-
Phenotype
Phenotype resulting from 2-O-acetyl-1-O-octadecyl-sn-glycero-3-phosphocholine
Phenotype where environments contain 2-O-acetyl-1-O-octadecyl-sn-glycero-3-phosphocholine
Phenotype modified by environments containing 2-O-acetyl-1-O-octadecyl-sn-glycero-3-phosphocholine
Human Disease Model